WINNIPEG, MB. – Health Canada and Pfizer announced that currently there is a shortage for the EpiPen auto-injectors.

Pfizer said the shortage for the EpiPen auto-injectors in the 0.3 mg format (DIN 00509558) due to a manufacturing disruption and is currently anticipated to be resolved by March 2, 2018. The shortage does not impact EpiPen Jr (0.15 mg) products, which remain available according to Pfizer.

Pfizer has advised that additional limited inventory will be available at the beginning of February 2018 and that it will continue to manage supply carefully. They are asking pharmacists to keep this shortage issue in mind when filling prescriptions.

EpiPen auto-injectors expire on the last day of the month as indicated on the product packaging. For example, if the product is marked as expiring in January it remains valid (not expired) until January 31. In general, it is recommended that people have more than one auto-injector with different expiry dates to avoid being in the situation of only having an expired auto-injector. However, with the shortage, if an individual is experiencing an anaphylactic reaction, Health Canada advises Canadians to use the expired product and immediately contact 911.

Kevin Klein, Manitoba Post

File photo